Elevated blood sugar levels are quite common among even non-diabetic patients presenting with acute myocardial infarction (or AMI). Does lowering a patient's glucose level actually improve outcomes, and if so, what glucose-control therapies are most effective for these patients? Dr. Mikhail Kosiborod, associate professor of medicine at the University of Missouri-Kansas City and cardiologist at St. Luke's Hospital Mid America Heart Institute in Kansas City, Missouri, reviews recent findings about glucose control and AMI with host Dr. Janet Wright.